In January 2023, Versanis launched a phase 2b human trial of bimagrumab as an obesity treatment, either alone or co-administered with semaglutide, Novo Nordisks GLP-1 agonist
GLP-1 drugs like Zepbound and Wegovy are often touted as the greatest thing since sliced bread, with research suggesting that they can help with weight loss, type 2 diabetes, and heart disease, and possibly even reduce the risk of both dementia and addiction
With the phenomenal and lucrative success of semaglutide and its far-reaching patent portfolio, it is to be expected that Novo Nordisks patents will be vulnerable to attack by other Big Pharma players in the weight loss drug arena who would like to clear the way before the natural expiry of the patents
80 , 282287 (2011) M
Set strategically Dust translucent powder over areas that tend to shine, like the T-zone, if you have oily skin or prefer a longer-lasting finish
Are Gimme Cares Medical Providers Licensed